Fast Five Quiz: High-Risk Myelodysplastic Syndrome

Emmanuel C. Besa, MD


February 03, 2021

Myelodysplastic syndrome (MDS) is a heterogeneous group of clonal stem cell disorders with an inherent tendency for leukemic transformation. MDS may involve one, two, or three myeloid hematopoiesis cell lineages — erythrocytic, granulocytic, megakaryocytic — depending on the subtype and stage of the disease.

Prognosis of MDS varies widely and is based on disease-specific factors such as bone marrow blast cells, chromosomal abnormalities, and hematopoietic insufficiency, as well as unique patient factors, including age, comorbidities, and transfusion requirement. About 30% of MDS cases progress to acute myeloid leukemia (AML).

How much do you know about high-risk MDS? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.